J Am Pharm Assoc (2003). 2023 Sep-Oct;63(5):1607-1611.e2. doi: 10.1016/j.japh.2023.06.002. Epub 2023 Jun 7.
Hormonal contraceptives are a popular option for pregnancy prevention and other indications and require a prescription. Since 2013, 24 states have given pharmacists legal authority to initiate self-administered hormonal contraceptives, allowing for direct pharmacy access (DPA). New York State (NYS) did not allow for DPA of any hormonal contraceptives during the survey period, but passed a bill in 2023 allowing pharmacists to dispense hormonal contraceptives in accordance with a nonpatient-specific order.
This study aimed to characterize the experiences, perceptions, and knowledge of access to and DPA to hormonal contraceptives.
A survey was developed to gather responses to demographic- and opinion-related questions and administered online using the Pollfish survey platform. Participants were women between the ages of 16 and 44 years who lived in NYS. To ensure geographic representation, at least one response was gathered from each of the 27 NYS congressional districts. Chi-square tests were used to assess differences in hormonal contraceptive use by patient demographics.
Most of the 500 respondents reported past (76.2%) or current/planned (76.8%) use of hormonal contraceptives. Older age (P = 0.033) and higher income (P = 0.0016) were associated with significantly greater rates of use. The most common challenges when visiting a provider for birth control included needing to schedule an appointment and wait times at the provider. Almost three-quarters of respondents (72.6%) were not aware that pharmacists could initiate contraceptives in other states, and 74.2% reported feeling comfortable with a pharmacist prescribing and dispensing hormonal contraceptives.
Contraceptive initiation by pharmacists would be acceptable to most respondents, but there is room for increased acceptance based on patient education and experience. DPA to hormonal contraceptives may eliminate some of the barriers identified in this survey.
激素避孕药是预防怀孕和其他适应症的常用选择,需要处方。自 2013 年以来,24 个州已赋予药剂师启动自我管理激素避孕药的合法权力,允许直接从药房获得(DPA)。在调查期间,纽约州(NYS)不允许任何激素避孕药的 DPA,但在 2023 年通过了一项法案,允许药剂师根据非患者特定的医嘱发放激素避孕药。
本研究旨在描述获取和 DPA 激素避孕药的经验、看法和知识。
开发了一项调查,以收集与人口统计和意见相关问题的回答,并使用 Pollfish 调查平台在线进行管理。参与者是年龄在 16 至 44 岁之间的居住在 NYS 的女性。为了确保地域代表性,从 NYS 的 27 个国会选区中至少收集了一个回应。卡方检验用于评估患者人口统计学特征与激素避孕药使用之间的差异。
500 名受访者中的大多数报告过去(76.2%)或当前/计划(76.8%)使用激素避孕药。年龄较大(P=0.033)和收入较高(P=0.0016)与使用率显著增加相关。就诊时获取避孕药具最常见的挑战包括需要预约和在提供者处等待时间。近四分之三(72.6%)的受访者不知道药剂师可以在其他州启动避孕药具,74.2%的人表示对药剂师开处方和发放激素避孕药感到放心。
大多数受访者可以接受药剂师启动避孕药具,但基于患者教育和经验,接受程度还有提高的空间。DPA 激素避孕药可能会消除调查中发现的一些障碍。